Project Loan NPA Resolution Incomplete
Despite INR 400 crore reduction in project loan outstanding, Stage 3 remains at 42.12% with INR 4,874 crore EAD. MD committed to exploring ARC sales and OTS for first time, but execution timeline uncertain.
LIC Housing Finance · risk themes across the available quarters.
Bear-case history
Despite INR 400 crore reduction in project loan outstanding, Stage 3 remains at 42.12% with INR 4,874 crore EAD. MD committed to exploring ARC sales and OTS for first time, but execution timeline uncertain.
Analyst raised concern about persistent GNPA elevation even excluding technical glitches. Project loans (42% NPA) and LAP (7.8% NPA) remain structurally weak segments dragging overall portfolio quality.
CFO deflected direct question on whether margins have peaked, only stating 'substantial improvement' for full year. Analyst noted 3.21% Q1 NIM vs 2.41% full-year FY23 seems elevated given stable yield/cost metrics.
Investor raised concern about 2-3 year CEO rotation from LIC nominees disrupting organizational continuity, noting new MD will take 1-2 years to learn business before potential transfer. Management acknowledged point but deferred to LIC.
Q1 portfolio growth of 4% vs double-digit guidance creates execution risk. High prepayment and rewrite pressures (INR 11,000-12,000 crore quarterly book erosion) may continue to offset disbursement growth.
NPA interest income highly volatile - dropped from INR 230 crore in Q4 to INR 90 crore in Q1. Normalized guidance of INR 130-140 crore may not materialize if NCLT resolutions face further delays.
Analyst raised sharp decline in Stage 1/2 provisioning (INR 121 crore reversal from cured accounts). Management explained ECL model mechanics but acknowledged volatility in provision coverage metrics.
Three large accounts (INR 250 crore, INR 400 crore, INR 375 crore) in NCLT awaiting resolution with 'green shoots' mentioned but no firm timeline. Additional technical write-offs of INR 400-500 crore expected.
CEO explicitly stated preference for margins over growth if faced with choice. PSU banks offering rates below 7.5% may constrain disbursement growth to 7-8% range rather than double-digit target.
Stage 3 NPA increased by INR 514 crore in Q1, entirely in retail segment, attributed to seasonal collection efficiency issues. Whether this is truly seasonal or structural remains uncertain.
Management acknowledged being 'slightly delayed' in passing rate cuts vs. repo-linked banks, resulting in loss of near-term disbursement momentum. Customers may have already moved to competitors.
Monthly BT at 0.10% may appear manageable but represents INR 1,000 crore quarterly leaving the book. Rewrite facility at 8.75% and top-up loans may not fully stem attrition as competition intensifies.
Provision coverage ratio declined from 44% to 41% following Q2 write-offs. Management committed to reaching 50% but provided no timeline. Analyst Mohit Jain specifically questioned credit cost guidance; CFO attributed decline partly to write-off mechanics.
MD acknowledged project loans as 'achilles heel' with ~40% NPA ratio. Legacy loans from 5+ years ago driving stress. Management remains selective but committed to continuing the segment. INR 400-500 crore resolution expected in Q3 from NCLT/OTS routes.
Q2 saw INR 9,291 crore of customer repricing (vs. zero in Q1 due to tech issues), with ~200bps rate reduction. MD expects Q3 rewriting to normalize to INR 3,000-4,000 crore. Combined with high-yield builder loan prepayments, margins face sequential pressure.
Balance transfers out were INR 2,300 crore vs. INR 1,200 crore inbound (~INR 1,100 crore net outflow). MD attributed part to technology-related servicing issues. Run rate has stabilized at 3-4% annualized but competitive pricing from banks remains a structural threat.
Analyst questioned 27bps yield decline in H1FY25 despite industry rates rising and minimal portfolio mix change. CFO attributed to growth focus over margins and portfolio rebuilding after prior year underperformance. No clear floor identified for yield stabilization beyond NIM guidance.
Analyst flagged stage 2 provision coverage ratio declining from 7% to 4% YoY. CFO attributed this to completion of OTR (one-time restructuring) post-COVID, which had required elevated provisions despite performing status. However, PCR trajectory if portfolio stress emerges could be inadequate.
Liabilities reprice immediately (banking) or month-end (T-bill), while assets reset only quarterly (first of quarter). Management acknowledged ~50% of liabilities will reprice faster than 90-95% of assets, creating potential margin pressure in rate cut scenarios rather than benefit.
Management accelerating developer lending after six quarters of caution, targeting INR 1,500+ crores quarterly disbursements. Despite BBB+ rating requirement, historical project finance NPA remains elevated at 30.13%. Single-lien security does not guarantee resolution speed given IBC delays and multiple stakeholder interests.
BT outs doubled to INR 4,000 crore in Q2 (vs INR 2,000 crore run rate), causing approximately INR 2,000 crore of book erosion. While October data shows normalization, any further rate differential with PSU banks (offering 7.35-7.50%) could trigger renewed outflows at the 8% rewriting rate floor.
H1 construction finance disbursements of INR 156 crore represent a INR 900+ crore shortfall vs H1 FY25. While yield improved to 12%+, the pipeline of INR 4,000+ crore undisbursed sanctions must convert in Q3-Q4 to meet the INR 5,000 crore annual target—execution risk is elevated.
PSU banks are offering home loans at 7.35% and construction finance at near-retail rates, creating persistent pricing pressure. Management has drawn a line at protecting margins over volume, but this structural constraint could limit market share recovery if sustained. The CEO explicitly deferred addressing this in analyst Q&A.
87% of business flows through third-party agents who are freelancers distributing across multiple lenders. Management acknowledged this structural vulnerability but deferred structural changes to the ongoing 3-6 month consultant review, creating near-term growth ceiling.
40.75% NPA in NHC/project segment (INR ~6,100 crore Stage 3 EAD on INR 15,000 crore wholesale book) creates uncertainty around credit costs and capital deployment efficiency. While 40-50 accounts are in resolution, timelines remain unpredictable.
Banks offering prime borrowers home loans at 8.3-8.35% vs LIC HFL's cost of funds at 7.70%, creating margin pressure. Management acknowledged difficulty competing with banks' lower cost of capital and is pivoting toward affordable housing segment.
Analyst Kunal Shah highlighted sequential decline in Stage 1 and Stage 2 coverage ratios, with Stage 1 provisioning dropping to ~20bps from 25bps. Management attributed this to curing period completions returning to ECL model, but incremental provisioning discipline on migration remains a monitoring point.
Management declined to provide FY2025 growth guidance, citing March board strategy meeting. "Consolidation year" framing and tech/digital investments in FY2025 raise questions about whether 15%+ book growth targets will be achieved.
Analyst Mahrukh Adajania highlighted that LIC HFL's PLR repricing lags banks, creating balance transfer risk when rate cuts begin. Management response relies on liquidity easing and PLR hike, but execution uncertainty remains given competitive banking sector.
Affordable housing strategy untested at scale. MD acknowledged 'not jumping into it' and building over 2-3 years with separate vertical. Biggest pure-play Aadhar has ~INR 20,000 crore book—LIC HFL's 3x larger base makes incremental affordable growth less impactful.
MD stated 'four or five cases at advanced stages of resolution' but could not confirm certainty. Abhijit Tibrewal's follow-up on Q4 recovery quantum and FY26 credit cost guidance was addressed with 20bps steady-state provision guidance but specific account-level details withheld.
MD stated 'I expect Bangalore also, the government is working on it' but simultaneously acknowledged 'still a huge backlog of cases pending for registration.' Q4 guidance predicated on this resolution materializing.
MD and CEO Tribhuwan Adhikari superannuates on August 31, 2026. Given the strategic transformation underway, leadership transition poses execution risk at a critical juncture.
Project loan Stage 3 of INR 3,416 crore comprises legacy loans in various courts and DRT/NCLT stages. Management noted two cases nearly resolved in Q3 but borrowers backtracked at the last minute. These large tickets remain unpredictable.
An analyst directly asked whether the company would consider onboarding a strategic investor (referencing PNB's earlier example). Management responded 'not in the discussion horizon,' without elaboration on board-level deliberations.
Management admitted that credit appraisal SOPs have been 'adjusted' to match bank competition, stating they have become 'more conducive to the market environment.' This could create future asset quality stress if borrower profiles have weakened.
Management guided NIM to 2.7%-2.9% for FY25 (vs 3.08% in FY24), acknowledging that RBI rate cuts would pressure margins. Rate cuts would be passed to borrowers with roughly one-quarter lag.
Cost of funds increased 13bps YoY to 7.76% and 6bps sequentially in Q4. Incremental cost of funds stood at 7.90% for Q4 vs 7.84% full-year average, indicating continued funding cost pressure.
Technical write-off pool of ~INR 4,000 crore (predominantly builder book in litigation/IBC) has uncertain recoverability. Management declined to provide recovery estimate, noting litigation is a slow process.
Q4 PAT was impacted by ~INR 381 crore in one-off provisions (wage revision, gratuity change, DTL, ECL buffer). Excluding these, quarterly earnings would have been materially higher.
PSU banks have cut new home loan pricing by 50-60bps in the last three months, offering near-8% rates to existing customers switching institutions. This is increasing portfolio retention pressure and basis point stress on the existing loan book, requiring selective rate matching.
No big project loans were resolved in Q4 despite management expectations, as most remaining sticky loans are in litigation (NCLT, DRT, SAT). One INR 450 crore loan recently approved for restructuring won't exit NPA until May 2026. ARC basket sale failed to attract expression of interest.
Management acknowledges NIM will face pressure as the full 50bps repo rate cut transmits through borrowing costs and is passed to borrowers. Spread maintenance at 2.06% requires balancing competitive pricing with growth targets in a single-product company competing against banks with CASA advantages.
While incremental cost of funds has declined to 7.3% from 7.66%, the overall borrowing book of ~INR 270 lakh crore includes older high-cost term loans and NCDs that need to mature/retire. Full transmission to book cost will lag, creating a timing mismatch in margin optimization.
West Asia crisis driving crude oil spikes and INR weakness. Management flagged potential for rate hikes if situation deteriorates, which could impact both funding costs and borrower sentiment in the IHL segment.
CEO expressed concern about potential impact on key business centers (Bangalore, Chennai, Hyderabad, Gurgaon, Pune) that rely heavily on IT industry employment. These centers contribute significantly to the company's business.
Banks with lower cost of funds (linked to repo rate) are aggressively pricing IHL loans. Management acknowledged difficulty competing with lenders. Spread compressed 12bps YoY to 1.94%.
New initiatives including co-lending policy, aggregator partnerships (targeting INR 4,000-5,000 Cr), and affordable housing vertical (completely new segment) carry execution risks in a competitive environment.